Heart Closure Devices Market Outlook Signals Expansion To $5.42 Billion Through 2030

The heart closure devices market is poised for substantial growth as advancements in cardiac treatment continue to accelerate. This sector is witnessing increasing attention due to the rising prevalence of structural heart diseases and a growing preference for minimally invasive therapies. Let's explore the market's future outlook, key players, emerging trends, and segmentation to understand this dynamic industry better.

Projected Expansion of the Heart Closure Devices Market Size Through 2030
The heart closure devices market is set to experience significant growth, reaching a valuation of $5.42 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 11.9%. Several factors are propelling this upward trend, including the growing demand for catheter-based cardiac treatments and increased investments in managing structural heart conditions. The establishment of more specialized cardiac centers and a heightened focus on minimizing surgical risks also contribute to market growth. Additionally, ongoing technological innovations in device design enhance their effectiveness and safety. Key developments anticipated during the forecast period include greater adoption of transcatheter heart closure techniques, a surge in demand for minimally invasive cardiac devices, increased use of nitinol-based closure systems, broader structural heart intervention programs, and a stronger emphasis on procedural safety and efficacy.

Download a free sample of the heart closure devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20828&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Dominant Players Governing the Heart Closure Devices Industry
Several leading companies hold prominent positions within the heart closure devices market. These include Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Lepu Medical Technology Ltd., Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Merit Medical Systems Inc., Cordis Corporation, AtriCure Inc., Lifetech Scientific Corp., Sahajanand Medical Technologies, W. L. Gore And Associates Inc., Occlutech GmbH, NMT Medical Inc., Sorin Group Italia S.p.A., Vivasure Medical Limited, B Braun Interventional Systems, HeartStitch Inc., and MicroPort Scientific Corporation.
In a notable move in November 2023, Johnson & Johnson MedTech acquired Laminar Inc. for $400 million. This acquisition aims to strengthen Johnson & Johnson MedTech's product offerings in cardiac arrhythmia treatments and expand its presence in the left atrial appendage (LAA) closure device market. Laminar Inc., based in the United States, specializes in heart closure device manufacturing. This strategic acquisition also supports innovation efforts focused on stroke prevention for patients suffering from non-valvular atrial fibrillation.

Technological Innovations Shaping the Heart Closure Devices Market
Industry leaders are concentrating on developing advanced, low-profile, and ergonomic surgical LAA devices designed to improve procedural accuracy, visibility, and ease of use for physicians. These devices emphasize continuous closing force mechanisms to optimize tissue compression and provide safe, effective closure of the left atrial appendage.
For example, in August 2024, AtriCure, Inc., a US-based company specializing in cardiac surgical solutions, launched its AtriClip FLEX-Mini device, the smallest-profile surgical LAA closure device available. Building on the established AtriClip platform, this device features a fully enclosed design with parallel beams to ensure continuous closing force, enhanced visibility, and an ergonomic handle that allows single-handed placement. This innovation supports healthcare professionals in delivering safe, precise, and efficient management of atrial fibrillation patients.

View the full heart closure devices market report:
https://www.thebusinessresearchcompany.com/report/heart-closure-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Comprehensive Segmentation of the Global Heart Closure Devices Market
This report divides the heart closure devices market into several key segments:
1) By Product Type: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Left Atrial Appendage (LAA) Closure Devices, and Other Products.
2) By Material: Nitinol-Based Devices, Stainless Steel Devices, and Other Materials.
3) By Mode of Delivery: Transcatheter Delivery and Surgical Delivery.
4) By End Use: Hospitals, Ambulatory Surgical Centers (ASCs), Cardiac Catheterization Laboratories, and other end users.

Further classifications include:
- ASD Closure Devices: Self-expanding occluders, balloon-expandable occluders, and other types.
- VSD Closure Devices: Transcatheter, surgical, and other varieties.
- PFO Closure Devices: Double-disc occluders, single-disc occluders, and additional types.
- LAA Closure Devices: Occluders, clip systems, and other products.
- Other Products: Septal defect closure devices, endovascular closure devices, and other specialty closure instruments.

This detailed segmentation provides a clear framework to analyze the market, catering to diverse clinical needs and procedural preferences across regions.

New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.